Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII

Cytotherapy

Volumn 16, Issue 4, 2014, Pages 566-575

  Burrows, Gregory G ^a,b   Maziarz, Richard T ^a   Hunady, Karen ^c   Lehman, Nicholas ^c   Raber, Amy ^c   Deans, Robert J ^c,d   van't Hof, Wouter ^c,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c ATHERSYS INC   (United States)

^d National Center for Regenerative Medicine   (United States)

Author keywords

Fucosyltransferase VII; Human multipotent adult progenitor cells; Leukocyte extravasation; Transcriptional regulation

Indexed keywords

FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE VII; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT STEM CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; FUCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MICROVASCULAR ENDOTHELIAL CELL; MULTIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

FUCOSYLTRANSFERASE VII; HUMAN MULTIPOTENT ADULT PROGENITOR CELLS; LEUKOCYTE EXTRAVASATION; TRANSCRIPTIONAL REGULATION;

CELL ADHESION; CELL- AND TISSUE-BASED THERAPY; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LYMPHOCYTE ACTIVATION; MULTIPOTENT STEM CELLS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 84895800451     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.08.004     Document Type: Article

References (52)

1. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991, 67:1033-1036.
2. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995, 57:827-872.
3. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689.
4. McEver R.P., Zhu C. Rolling cell adhesion. Annu Rev Cell Dev Biol 2010, 26:363-396.
5. Wagers A.J., Stoolman L.M., Craig R., Knibbs R.N., Kansas G.S. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins. J Immunol 1998, 160:5122-5129.
6. Homeister J.W., Thall A.D., Petryniak B., Maly P., Rogers C.E., Smith P.L., et al. The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 2001, 15:115-126.
7. Chen G.Y., Osada H., Santamaria-Babi L.F., Kannagi R. Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes. Proc Natl Acad Sci U S A 2006, 103:16894-16899.
8. Somers W.S., Tang J., Shaw G.D., Camphausen R.T. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 2000, 103:467-479.
9. Kang Y., Lu S., Ren P., et al. Molecular dynamics simulation of shear- and stretch-induced dissociation of P-selectin/PSGL-1 complex. Biophys J 2012, 102:112-120.
10. Maly P., Thall A., Petryniak B., Rogers C.E., Smith P.L., Marks R.M., et al. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996, 86:643-653.
11. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
12. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002, 30:896-904.
13. Kovacsovics-Bankowski M., Mauch K., Raber A., Streeter P.R., Deans R.J., Maziarz R.T., et al. Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells. Cytotherapy 2008, 10:730-742.
14. Kovacsovics-Bankowski M., Streeter P.R., Mauch K.A., Frey M.R., Raber A., van't Hof W., et al. Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cell Immunol 2009, 255:55-60.
15. Maziarz R.T., Devos T., Bachier C., Goldstein S.C., Leis J., Cooke K.R., et al. Prophylaxis of acute GVHD using Multistem stromal cell therapy: preliminary results after administration of single or multiple doses in a phase 1 trial. Biol Blood Marrow Transplant 2012, 18:S264-S265.
16. Penn M.S., Ellis S., Gandhi S., Greenbaum A., Hodes Z., Mendelsohn F.O., et al. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circ Res 2012, 110:304-311.
17. Aranguren X.L., Luttun A., Clavel C., Moreno C., Abizanda G., Barajas M.A., et al. In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood 2007, 109:2634-2642.
18. Aranguren X.L., Pelacho B., Penuelas I., Abizanda G., Uriz M., Ecay M., et al. MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia. Cell Transplant 2011, 20:259-269.
19. Lehman N., Cutrone R., Raber A., Perry R., Van't Hof W., Deans R., et al. Development of a surrogate angiogenic potency assay for clinical-grade stem cell production. Cytotherapy 2012, 14:994-1004.
20. Walker P.A., Bedi S.S., Shah S.K., Jimenez F., Xue H., Hamilton J.A., et al. Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population. J Neuroinflamm 2012, 9:228.
21. Maziarz R.T., Newell L.F., Bogaerts A., Pinxteren J., Deans R., Burrows G. Dissection of the human multipotent adult progenitor cell (MAPC) secretome by proteomic analysis. Biol Blood Marrow Transplant 2013, 19:S350-S351.
22. Yasuhara T., Matsukawa N., Yu G., Xu L., Mays R.W., Kovach J., et al. Transplantation of cryopreserved human bone marrow-derived multipotent adult progenitor cells for neonatal hypoxic-ischemic injury: targeting the hippocampus. Rev Neurosci 2006, 17:215-225.
23. Yasuhara T., Matsukawa N., Yu G., Xu L., Mays R.W., Kovach J., et al. Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant 2006, 15:231-238.
24. Ulloa-Montoya F., Kidder B.L., Pauwelyn K.A., Chase L.G., Luttun A., Crabbe A., et al. Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 2007, 8:R163.
25. Rogge L., Bianchi E., Biffi M., Bono E., Chang S.Y., Alexander H., et al. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet 2000, 25:96-101.
26. Kannagi R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr Opin Struct Biol 2002, 12:599-608.
27. Kannagi R. Transcriptional regulation of expression of carbohydrate ligands for cell adhesion molecules in the selectin family. Adv Exp Med Biol 2001, 491:267-278.
28. Hiraiwa N., Yabuta T., Yoritomi K., Hiraiwa M., Tanaka Y., Suzuki T., et al. Transactivation of the fucosyltransferase VII gene by human T-cell leukemia virus type 1 Tax through a variant cAMP-responsive element. Blood 2003, 101:3615-3621.
29. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
30. Jacobs SA, Pinxteren J, Roobrouck VD, Luyckx A, Van't Hof W, Deans R, et al. Human multipotent adult progenitor cells are non-immunogenic and exert potent immunomodulatory effects on alloreactive T cell responses [published online ahead of print October 1, 2012]. Cell Transplant.
31. Rosen S.D. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004, 22:129-156.
32. Phillips M.L., Nudelman E., Gaeta F.C., Perez M., Singhal A.K., Hakomori S., et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990, 250:1130-1132.
33. Walz G., Aruffo A., Kolanus W., Bevilacqua M., Seed B. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 1990, 250:1132-1135.
34. Lowe J.B., Stoolman L.M., Nair R.P., Larsen R.D., Berhend T.L., Marks R.M. ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell 1990, 63:475-484.
35. Ohmori K., Takada A., Ohwaki I., Takahashi N., Furukawa Y., Maeda M., et al. A distinct type of sialyl Lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells. Blood 1993, 82:2797-2805.
36. Ohmori K., Fukui F., Kiso M., Imai T., Yoshie O., Hasegawa H., et al. Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skin-homing helper memory T cells. Blood 2006, 107:3197-3204.
37. Austrup F., Vestweber D., Borges E., Lohning M., Brauer R., Herz U., et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 1997, 385:81-83.
38. Natsuka S., Gersten K.M., Zenita K., Kannagi R., Lowe J.B. Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 1994, 269:16789-16794.
39. Knibbs R.N., Craig R.A., Natsuka S., Chang A., Cameron M., Lowe J.B., et al. The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J Cell Biol 1996, 133:911-920.
40. Wagers A.J., Stoolman L.M., Kannagi R., Craig R., Kansas G.S. Expression of leukocyte fucosyltransferases regulates binding to E-selectin: relationship to previously implicated carbohydrate epitopes. J Immunol 1997, 159:1917-1929.
41. Kimura N., Mitsuoka C., Kanamori A., Hiraiwa N., Uchimura K., Muramatsu T., et al. Reconstitution of functional L-selectin ligands on a cultured human endothelial cell line by cotransfection of alpha1-->3 fucosyltransferase VII and newly cloned GlcNAcbeta:6-sulfotransferase cDNA. Proc Natl Acad Sci U S A 1999, 96:4530-4535.
42. Barry S.M., Zisoulis D.G., Neal J.W., Clipstone N.A., Kansas G.S. Induction of FucT-VII by the Ras/MAP kinase cascade in Jurkat T cells. Blood 2003, 102:1771-1778.
43. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.
44. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
45. Yokoyama W.M. Betting on NKT and NK cells. Immunity 2004, 20:363-365.
46. Hwang E.S., Szabo S.J., Schwartzberg P.L., Glimcher L.H. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 2005, 307:430-433.
47. Kang B.Y., Miaw S.C., Ho I.C. ROG negatively regulates T-cell activation but is dispensable for Th-cell differentiation. Mol Cell Biol 2005, 25:554-562.
48. Yoon H.S., Scharer C.D., Majumder P., Davis C.W., Butler R., Zinzow-Kramer W., et al. ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells. J Immunol 2012, 189:2393-2403.
49. Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 2007, 8:825-834.
50. Patnaik S.K., Potvin B., Carlsson S., Sturm D., Leffler H., Stanley P. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells. Glycobiology 2006, 16:305-317.
51. Jouve N., Despoix N., Espeli M., Gauthier L., Cypowyj S., Fallague K., et al. The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells. J Biol Chem 2013, 288:2571-2579.
52. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 2009, 10:981-991.